anmelden
FTSE 100
10.844,19
PKT
-18,31
PKT
-0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.04.26 | Unilever Hold | Deutsche Bank AG | |
| 01.04.26 | Unilever Overweight | Barclays Capital | |
| 01.04.26 | National Grid Buy | Deutsche Bank AG | |
| 01.04.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.04.26 | Diageo Buy | Jefferies & Company Inc. | |
| 01.04.26 | Unilever Outperform | Bernstein Research | |
| 01.04.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 01.04.26 | Diageo Overweight | Barclays Capital | |
| 01.04.26 | BP Overweight | Barclays Capital | |
| 01.04.26 | National Grid Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Unilever Outperform | Bernstein Research | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Underperform | RBC Capital Markets | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 31.03.26 | BP Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | GSK Underweight | Barclays Capital | |
| 31.03.26 | Diageo Buy | Deutsche Bank AG | |
| 31.03.26 | Diageo Buy | Deutsche Bank AG | |
| 30.03.26 | Rio Tinto Equal-weight | Morgan Stanley | |
| 30.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.03.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 27.03.26 | BAT Neutral | JP Morgan Chase & Co. | |
| 27.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 27.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 27.03.26 | Unilever Overweight | Barclays Capital | |
| 27.03.26 | International Consolidated Airlines Sell | UBS AG | |
| 26.03.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 26.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 26.03.26 | BAT Buy | Deutsche Bank AG | |
| 26.03.26 | BP Buy | Goldman Sachs Group Inc. | |
| 26.03.26 | HSBC Buy | Goldman Sachs Group Inc. | |
| 26.03.26 | Diageo Overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
